Compounded Medication Safety: Best Practice
Monday, August 1, 2016
By Gary Rischitelli, MD, JD, MPH, FACOEM — Compounded medications continue to be a costly and frequently unnecessary expense in the treatment provided to injured workers in some jurisdictions. Their inappropriate use is largely driven by the substantial profits associated with compounding...
Read more

ODG Exits the National Guideline Clearinghouse
Wednesday, July 27, 2016
By Gary Rischitelli, MD, JD, MPH, FACOEM — Utilization management decisions should be based on the best available scientific and medical evidence. Depending on jurisdictional rules, medical evidence can be gleaned from multiple sources, including state-mandated medical treatment guideline...
Read more

Compounded Dermatological Medications: Handle with Care
Monday, June 27, 2016
By Mary Goris, RN, CRRN, Nurse Manager — In 2015, the average cost per prescription for a dermatological, one of the most common classes of compounded medications, saw an increase of almost 16%, according to the latest Workers' Compensation Drug Trend Report published by pharmacy ben...
Read more

Zika Virus
Tuesday, March 8, 2016
By Gary Rischitelli, MD, JD, MPH, FACOEM — Over the past several weeks, the Zika virus has been front page news. This is, in part, because of a potential association with a severe congenital malformation called microcephaly in the offspring of women infected with the Zika virus durin...
Read more

King v. CompPartners
Tuesday, March 8, 2016
By Gary Rischitelli, MD, JD, MPH, FACOEM — A recent legal decision in a California appeals court raised new concerns about the potential professional liability of peer reviewers performing utilization management in California. The legal issues in King were somewhat technical, and the...
Read more

Failed Backs and Scrapped Parts
Thursday, November 12, 2015
By Gary Rischitelli, MD, JD, MPH, FACOEM — One of the unique privileges of being an occupational health physician is the opportunity to step out of the health care sector and learn about other industries and how they function. The chance to learn "how things are made" and s...
Read more

In Case You Missed It
Wednesday, July 22, 2015
Earlier this month two members of our clinical leadership team — Gary Rischitelli, MD, JD, MPH, FACOEM, and Jean Chambers, MSN, RN, CCM — published a two-part Leaders Speak series on WorkCompWire. These articles, "Helping Patients Choose" and "Nurse Case Manageme...
Read more

Innovation Summit Webinar
Wednesday, July 22, 2015
Recently, we hosted two client engagement webinars on innovation, which stemmed from our popular client event at RIMS. For these events, we teamed up with our parent company, Xerox Corporation, to bring our audience the latest and most promising breakthroughs in the marketplace. We selected inn...
Read more

Tapering: Whose Responsibility Is It?
Monday, April 27, 2015
By Gary Rischitelli, MD, JD, MPH, FACOEM — When a utilization management clinical peer reviewer (CPR) is unable to certify the ongoing use of an opioid medication as medically reasonable and necessary, is the CPR obligated to provide tapering? In general, a CPR is only asked to prov...
Read more

Managing Uncertainty in Evidence-based Medicine
Monday, February 2, 2015
By Gary Rischitelli, MD, JD, MPH, FACOEM — Recently, a colleague of mine handed me an article from a back issue of the Journal of The American Medical Association and asked for my impression of it. It was a commentary titled “EBM’s Six Dangerous Words” (Braithwaite ...
Read more

Medical Board of California Revises Guidelines
Thursday, December 11, 2014
By Gary Rischitelli, MD, JD, MPH, FACOEM — In November, the Medical Board of California (Board) released revised Guidelines for Prescribing Controlled Substances for Pain (Guidelines) following approval at its quarterly board meeting on October 24, 2014. Acknowledging the current na...
Read more